The transfer of proteins or genetic material from exosomes and the subsequent effects on cell fate are well described.[@cit0001] However lipids effects on cell behavior remain less documented.[@cit0002] Few years ago Ristorcelli[@cit0003] reported that the human pancreatic cancer SOJ-6 and BxPc-3 cells, 2 differentiated cancer cell lines are sensitive to exosomes whereas poorly differentiated MiaPaCa-2 and Panc-1 cells are (quite) insensitive. SOJ-6 cells expressed exosomes, rich in lipid-forming rafts, which further interacted with cell membrane to disturb the Notch-1 survival pathway. In particular the γ-secretase, cleaving Notch-1 in the active Notch IntraCytoplasmic Domain (NICD), is sensitive to lipid microenvironment.[@cit0005] These effects on Notch functioning down-regulate the phosphorylation of the pro-apoptotic PTEN and GSK-3β leading to their activation. GSK-3β inhibits mitochondrial PDH, up-regulates pro-apoptotic Bax protein, down-regulates anti-apoptotic Bcl^-^2, Hes-1 (a nuclear target of the Notch pathway) and cyclin D1 expressions promoting the arrest of the cell cycle in the G~0~-G~1~ transition phase. To demonstrate the implication of exosomal lipids in promoting the death of SOJ-6 cells, Beloribi[@cit0006] synthesized exosome-like nanoparticles (SELN) solely composed of lipids among which lipid-forming rafts predominate. The size of SELN, which appear stable with time, is compatible with a fusion/exchange with rafts in cell membranes. SELN co-localize with Notch-1 and with GangliosideM1 (GM1, a marker of rafts) at the level of plasma membrane and with Notch-1 and Rab5A at the level of early endosomes. Therefore data presented by Beloribi[@cit0006] fit with a fusion/exchange of lipid SELN with rafts at the plasma membrane followed by endocytosis and/or with a fusion/exchange with rafts of the endosomal membrane. Beloribi[@cit0006] further showed that SELN mimicked the effects of exosomes and concluded that exosomal lipids alone could be responsible for the death of differentiated pancreatic tumor SOJ-6 cells. To further establish the involvement of rafts lipid the ratio Lo/Ld (i.e., lipids forming rafts versus non-raft lipids) was varied and higher the ratio Lo/Ld (i.e., the amount of raft lipids), greater the detrimental effects on SOJ-6 cells. Beloribi[@cit0006] concluded that the raft lipids of SELN are responsible for SOJ-6 cells death. On another hand MiaPaCa-2 pancreatic cells, which are considered as a stem-like cancer (or initiating cancer) cell model as they are ALDH-positive and CD44-positive (among others) were insensitive to exosomes[@cit0003] and SELN.[@cit0006] The difference in sensitivity to SELN could be due to different genetic backgrounds of SOJ-6 and MiaPaCa-2 cells. PTEN (a Notch partner) mutations have been involved in the resistance to Notch inhibition. However PTEN is rarely mutated in pancreatic adenocarcinomas and SOJ-6 and MiaPaCa-2 cells expressed wild-type PTEN. Notch also represses stem/progenitor cell expansion *via* p53 tumor suppressor protein. However p53 mutations have been observed in DNA specific binding domain in both exosomes-sensitive SOJ-6 and exosomes-insensitive MiaPaCa-2 cells and consequently cannot be the source of observed differences. Therefore the mechanisms of the MiaPaCa-2 cells resistance to exosomal lipids are somewhere else. In a recent paper Beloribi-Djefaflia[@cit0007] aimed at deciphering the reason(s) of this resistance. In the presence of SELN, the expression of NICD decreases in MiaPaCa-2 cells but neither Hes-1, the nuclear target of NICD, nor the ratio Bax/Bcl^-^2 were affected. Beloribi-Djefaflia[@cit0007] concluded that Notch pathway was obviously affected in MiaPaCa-2 cells exposed to SELN without deleterious effects. Authors further showed that in MiaPaCa-2 cells SELN induced the activation of NF-*k*B, thus promoting the expression and the secretion of SDF-1α. Oncogenic *Kras* (a signature of pancreatic adenocarcinoma) acting as an upstream activator of Akt can stimulate the transcriptional activity of NF-*k*B which is constitutively activated in almost 70% of pancreatic cancers. Therefore authors showed that MiaPaCa-2 cells harbor the *K*ras p-Gly12Cys mutation and hypothesized that once the fusion had occurred non-rafts lipids of SELN may freely diffuse within the cell membrane compartment to impact on the constitutively active oncogenic *K*ras which exhibits stable interaction with the inner leaflet of plasma membrane at saturable non-raft sites. Such interaction is required for efficient signaling of GTP-loaded Ras proteins. Therefore the fusion of SELN with plasma membrane may affect the Ras location and facilitate signaling with the efficient activation of underneath proteins. SELN, impacting on *K*ras functioning, may lead to a significant over-expression of GSK-3β as observed with MiaPaCa-2 cells upon SELN incubation,[@cit0006] to the over-activation of NF-*k*B, to its subsequent transcription activity on SDF-1α expression and secretion. Once secreted the α-chemokine interacts with its dedicated receptor CXCR4 on MiaPaCa-2 cells and activates the Akt survival pathway protecting cells from death. Consequently the SDF-1α-CXCR4 axis is activated by SELN and counteracts their inhibitory effects on the Notch-1 pathway (**Fig. 1**). MiaPaCa-2 cells are resistant to Gemcitabine, the gold standard for pancreatic adenocarcinoma treatment and Beloribi-Djefaflia[@cit0007] also reports that SELN were able to reverse the survival inhibition promoted by cyclopamine on MiaPaCa-2 cells *via* the Hedgehog embryonic pathway. Therefore it can be hypothesized that cancer cells in part those with cancer stem-like cell features take advantage of the predominating CXCR4-SDF-1α axis to resist to drugs and to self-renew. Part of these fates could be maintained *via* paracrine effects of differentiated cells which may release factors among them lipid vesicles able to promote stem-like (or initiating) cancer cells survival. Future therapies should focus on this dialog.[ ](#f0001){ref-type="fig"} Figure 1.Cells express exosomes comprising lipids however lipids impact on cancer cells according to cell phenotype. On cancer stem-like cells, lipids activate the NF-*k*B pathway to promote SDF-1α expression/secretion and the activation of the CXCR4-SDF-1α survival axis. On differentiated cancer cells, exosomes inhibit the NOTCH survival pathway to promote apoptosis. Therefore exosomal lipids participate in tumor growth and resistance to drugs.
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